Dasatinib (Sprycel) - Oncology Nurse Advisor
Skip to navigation Skip to main content

Dasatinib (Sprycel)

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews dasatinib (Sprycel), indicated for newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic lymphoma (ALL) with resistance or intolerance to prior therapy.

Topics:

Drug Information Slideshows Stat Consult
Next hm-slideshow in Slides